Home » Topics » Regulatory

Regulatory
RSS

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Shire launches Intuniv in the U.S. for ADHD in children and adolescents

Nov. 9, 2009

FDA approves Gloucester's Istodax for cutaneous T-cell lymphoma

Nov. 9, 2009

Novartis' influenza A(H1N1) vaccine Celtura approved in Germany

Nov. 6, 2009

Canadian marketing approval for BioMimetic Therapeutics' Augment Bone Graft

Nov. 5, 2009

FDA grants accelerated approval to GSK and Genmab's Arzerra antibody in CLL

Oct. 28, 2009

FDA approves Votrient for advanced renal cell cancer

Oct. 21, 2009

FDA approves Boehringer Ingelheim's Twynsta for hypertension treatment

Oct. 21, 2009

Dainippon Sumitomo's Miripla granted Japanese manufacturing and marketing approval

Oct. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...